As the 2024 presidential election approaches, the rival campaigns have promised to “lower costs” on healthcare for people ...

Torrent Pharmaceuticals, a leading player in the pharmaceutical industry, announced on Friday that it has received a Form 483 ...

Flu season approaches and there's a new COVID variant. The time to act is now, or soon, according to the two largest local hospital systems.

New Food and Drug Administration regulations went into effect on Sept ... experts and politicians to change the protocol ...

In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...

Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company dedicated to developing transformative therapies for rare diseases with serious unmet needs, today ...

With rising rates of obesity in the U.S. and increasing attention being paid to the health harms of processed foods, it's ...

The lawsuit between the state of Arkansas and a major dollar store retailer over the infestation of rats and other vermin in ...

The bill's passage through the committee improves the rare pediatric disease priority review voucher program's chances of being reauthorized before it expires Sept. 30.

With rising rates of obesity in the U.S. and increasing attention being paid to the health harms of processed foods, it's clear that far more could be done to help consumers make healthy food choices.

reaffirms its commitment to improving the lives of patients suffering from diabetic gastroparesis in light of the recent decision by the U.S. Food and Drug Administration (FDA) to not approve Vanda ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the ...